Phase 2 Lupus Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to sign a consent form agreeing to take part voluntarily.
- You are between 18 and 65 years old (male or female).
- You have been diagnosed with lupus (SLE) meeting at least 4 out of 11 specific medical criteria, and your disease is currently considered moderately to severely active based on a standard scoring system.
- You have previously tried a combination of treatments for lupus (such as steroids with other medicines), but either could not tolerate them or they did not work well enough.
- You have been diagnosed with a specific type of kidney inflammation caused by lupus (called lupus nephritis, class III or IV, with or without class V), confirmed by a kidney biopsy.
- Your urine tests show a significant amount of protein leaking into your urine, above a certain level (confirm with trial site for exact values).
- You agree not to try to become pregnant or donate sperm or eggs during the trial and for at least 1 year afterward, and you agree to use effective contraception during this time.
Who may not be able to join:
- You have serious liver problems, shown by certain blood test results being more than twice the normal range.
- Your kidneys are functioning very poorly, based on specific blood or lab measurements falling below or above set levels.
- Your kidney biopsy shows that 50% or more of the filtering units in your kidneys are permanently scarred.
- Your blood counts are very low in any of the following areas: white blood cells, red blood cells (causing severe anaemia), platelets, or a specific type of infection-fighting cell called neutrophils.
- You have a serious, uncontrolled condition affecting your heart, lungs, nervous system, liver, hormones (such as uncontrolled diabetes), or digestive system — including very high blood pressure, significant heart failure, a heart attack in the last 6 months, a stroke in the last 6 months, severe high blood pressure in the lungs, or serious heart rhythm problems.
- You have a history of a condition where your immune system does not produce enough of a protein called IgA.
- You have another autoimmune disease in addition to lupus (such as rheumatoid arthritis or systemic sclerosis), although having a secondary condition called Sjögren's syndrome is allowed.
- You have received a live or weakened live vaccine in the past 12 weeks, or expect to need one during the trial.
- You have had a specific blood-cleaning treatment (plasmapheresis or immunoadsorption) in the past 24 weeks, or received a treatment called IVIG in the past 4 weeks.
- You have taken part in another clinical drug trial in the past 12 weeks.
- You have tested positive for HIV, active syphilis, active hepatitis C, or hepatitis B (at certain levels), or you have had a serious or recurring infection recently.
- You have been diagnosed with any cancer in the past 5 years, including blood cancers or tumours in organs (except certain fully treated skin cancers).
- You have had major surgery in the past 12 weeks, or are expected to need major surgery during the trial, which the trial doctor considers too risky.
- You are allergic to the treatment used in this trial (which involves stem cells) or to any of its ingredients, including human albumin; or you cannot take steroid medicines; or you do not have a suitable vein for an intravenous drip.
- You are currently pregnant or breastfeeding.
- In the past 12 months, you have smoked 5 or more cigarettes a day on average, regularly drunk more than 14 units of alcohol per week, or have used illegal drugs or tested positive on a drug screening test.
- The trial doctor has decided for any other reason that the trial may not be suitable for you (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sun Lingyun, the Affiliated Drum Tower Hospital, Medical School, Nanjing University
Phone: 15852926678
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Frequency of Adverse Events; Proportion of patients achieving a primary renal efficacy response (PERR); Proportion of patients achieving a complete response (CR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.